Ohtake Shiori, Kimata Koji, Habuchi Osami
Department of Chemistry, Aichi University of Education, Igaya-cho, Kariya, Aichi 448-8542, Japan.
J Biol Chem. 2005 Nov 25;280(47):39115-23. doi: 10.1074/jbc.M508816200. Epub 2005 Sep 27.
We have shown previously that a highly sulfated sequence, GalNAc(4,6-SO(4))-GlcA(2SO(4))-GalNAc(6SO(4)), is present at the nonreducing terminal of chondroitin sulfate (CS), and this structure was synthesized from a unique sequence, GalNAc(4SO(4))-GlcA(2SO(4))-GalNAc(6SO(4)), by sulfation with N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase. Uronosyl 2-O-sulfotrasferase (2OST), which transfers sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to position 2 of the GlcA residue of CS, is expected to be involved in synthesis of these structures; however, the specificity of 2OST concerning recognition of the sulfation pattern of the acceptor has largely remained unclear. In the present study, we examined the specificity of 2OST in terms of recognition of the sulfation pattern around the targeting GlcA residue. The recombinant 2OST could sulfate CS-A, CS-C, and desulfated dermatan sulfate. When [(35)S]glycosaminoglycans formed from CS-A after the reaction with the recombinant 2OST and [(35)S]PAPS were subjected to limited digestion with chondroitinase ACII, a radioactive tetrasaccharide (Tetra A) was obtained as a sole intermediate product. The sequence of Tetra A was found to be DeltaHexA-GalNAc(4SO(4))-GlcA(2SO(4))-GalNAc(6SO(4)) by enzymatic and chemical reactions. These observations indicate that 2OST transfers sulfate preferentially to the GlcA residue located in a unique sequence, -GalNAc(4SO(4))-GlcA-GalNAc(6SO(4))-. When oligosaccharides with different sulfation patterns were used as the acceptor, GalNAc(4SO(4))-GlcA-GalNAc(6SO(4)) and GlcA-GalNAc(4SO(4))-GlcA-GalNAc(6SO(4)) were the best acceptors for 2OST among trisaccharides and tetrasaccharides, respectively. These results suggest that 2OST may be involved in the synthesis of the highly sulfated structure found in CS-A.
我们之前已经表明,一种高度硫酸化的序列,即GalNAc(4,6 - SO(4)) - GlcA(2SO(4)) - GalNAc(6SO(4)),存在于硫酸软骨素(CS)的非还原末端,并且这种结构是由一个独特的序列GalNAc(4SO(4)) - GlcA(2SO(4)) - GalNAc(6SO(4))通过N - 乙酰半乳糖胺4 - 硫酸6 - O - 磺基转移酶硫酸化而合成的。将硫酸从3'-磷酸腺苷5'-磷酸硫酸酯(PAPS)转移至CS的GlcA残基2位的糖醛酸2 - O - 磺基转移酶(2OST)预计参与这些结构的合成;然而,2OST关于识别受体硫酸化模式的特异性在很大程度上仍不清楚。在本研究中,我们从识别靶向GlcA残基周围硫酸化模式的角度研究了2OST的特异性。重组2OST能够使CS - A、CS - C和去硫酸化的硫酸皮肤素硫酸化。当与重组2OST和[(35)S]PAPS反应后由CS - A形成的[(35)S]糖胺聚糖用软骨素酶ACII进行有限消化时,得到一种放射性四糖(四糖A)作为唯一的中间产物。通过酶促和化学反应发现四糖A的序列为ΔHexA - GalNAc(4SO(4)) - GlcA(2SO(4)) - GalNAc(6SO(4))。这些观察结果表明,2OST优先将硫酸转移至位于独特序列 - GalNAc(4SO(4)) - GlcA - GalNAc(6SO(4)) - 中的GlcA残基。当使用具有不同硫酸化模式的寡糖作为受体时,GalNAc(4SO(4)) - GlcA - GalNAc(6SO(4))和GlcA - GalNAc(4SO(4)) - GlcA - GalNAc(6SO(4))分别是三糖和四糖中2OST的最佳受体。这些结果表明,2OST可能参与了CS - A中发现的高度硫酸化结构的合成。